Theravance Inc (THRX)

10.03
0.16 1.57
NASDAQ : Health Care
Prev Close 10.19
Open 10.15
Day Low/High 10.01 / 10.29
52 Wk Low/High 6.36 / 16.81
Volume 815.56K
Avg Volume 868.80K
Exchange NASDAQ
Shares Outstanding 117.43M
Market Cap 1.15B
EPS -1.50
P/E Ratio N/A
Div & Yield 1.00 (10.20%)
Insider Trading Alert - SPLK, ARE And THRX Traded By Insiders

Insider Trading Alert - SPLK, ARE And THRX Traded By Insiders

Stocks with insider trader activity include SPLK, ARE and THRX

Top Insider Trades: THRX AYR SFLY JEC

Top Insider Trades: THRX AYR SFLY JEC

The top 10 open-market insider purchases and sales filed at the SEC Thursday.

Barbarian At The Gate: Theravance (THRX)

Barbarian At The Gate: Theravance (THRX)

Trade-Ideas LLC identified Theravance (THRX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Interesting THRX Put And Call Options For February 22nd

Interesting THRX Put And Call Options For February 22nd

Investors in Theravance Inc saw new options become available this week, for the February 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the THRX options chain for the new February 22nd contracts and identified one put and one call contract of particular interest.

Notable Two Hundred Day Moving Average Cross - THRX

Notable Two Hundred Day Moving Average Cross - THRX

In trading on Monday, shares of Theravance Inc crossed below their 200 day moving average of $36.66, changing hands as low as $35.61 per share. Theravance Inc shares are currently trading off about 3.5% on the day.

The Twitterverse's Biotech Stock Picks for 2014

The Twitterverse's Biotech Stock Picks for 2014

Biotech Twitter gets a chance to predict which stocks are worth buying this year.

Commit To Purchase Theravance At $25, Earn 9.2% Using Options

Commit To Purchase Theravance At $25, Earn 9.2% Using Options

Investors eyeing a purchase of Theravance Inc stock, but cautious about paying the going market price of $35.25/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $25 strike, which has a bid at the time of this writing of $2.30.

Theravance Larger Than S&P 500 Component Allegheny Technologies

Theravance Larger Than S&P 500 Component Allegheny Technologies

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Theravance Inc was identified as having a larger market cap than the smaller end of the S&P 500, for example Allegheny Technologies, Inc , according to The Online Investor. Market capitalization is an important data point for investors to keep an eye on, for various reasons.

Theravance Inc. (THRX): Today's Featured Health Care Laggard

Theravance Inc. (THRX): Today's Featured Health Care Laggard

Theravance was a leading decliner within the health care sector, falling $0.48 (-1.4%) to $34.50 on heavy volume

5 Trades to Take From the Health Care Sector

5 Trades to Take From the Health Care Sector

While Congress battles it out over Obamacare on Capitol Hill, tradable setups are popping up in health care stocks.

Increased Odds of a Slide

After three days of testing, a lot depends on Thursday's open, with overnight support favoring another recovery attempt.

Insider Trading Alert - BofI And 4 Others Traded By Insiders

Insider Trading Alert - BofI And 4 Others Traded By Insiders

Stocks with insider trader activity include BOFI, LGND, THRX, NBL and TAL

Theravance Inc. (THRX): Today's Featured Health Care Winner

Theravance Inc. (THRX): Today's Featured Health Care Winner

Theravance was a winner within the health care sector, rising $2.45 (6.3%) to $41.19 on heavy volume

Trade-Ideas: Theravance (THRX) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas: Theravance (THRX) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas LLC identified Theravance (THRX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

7 Stocks Moving on Unusual Volume

7 Stocks Moving on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Theravance Inc. (THRX): Today's Featured Drugs Winner

Theravance Inc. (THRX): Today's Featured Drugs Winner

Theravance was a winner within the drugs industry, rising $0.39 (1.1%) to $37.20 on light volume

5 Stocks With Big Insider Buying

5 Stocks With Big Insider Buying

Insiders at these companies are scooping up shares of their own stock lately.

The Deal: Elan Agrees on $8.6B Takeover by Perrigo

The Deal: Elan Agrees on $8.6B Takeover by Perrigo

Elan said it had agreed on an $8.6 billion takeover by pharmaceuticals company Perrigo.

Theravance Inc. (THRX): Today's Featured Health Care Laggard

Theravance Inc. (THRX): Today's Featured Health Care Laggard

Theravance was a leading decliner within the health care sector, falling $0.69 (-1.9%) to $36.60 on light volume

Theravance Inc. (THRX): Today's Featured Drugs Laggard

Theravance Inc. (THRX): Today's Featured Drugs Laggard

Theravance was a leading decliner within the drugs industry, falling $0.55 (-1.3%) to $42.09 on light volume

Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now

Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now

Royalty Pharma is going to court to re-instate its hostile tender offer for Elan following a shareholder vote.

Commit To Purchase Theravance At $25, Earn 13.2%

Commit To Purchase Theravance At $25, Earn 13.2%

Investors considering a purchase of Theravance Inc stock, but cautious about paying the going market price of $35.86/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $25 strike, which has a bid at the time of this writing of $3.30.

Theravance Inc. (THRX): Today's Featured Drugs Laggard

Theravance Inc. (THRX): Today's Featured Drugs Laggard

Theravance was a leading decliner within the drugs industry, falling $0.43 (-1.2%) to $35.38 on average volume

Stocks Finish Flat as Earnings Wind Down

Stocks Finish Flat as Earnings Wind Down

Stocks traded sideways following last week's gain even as April retail sales show improvement.

Stock Futures Pare Losses After Retail Sales Number

Stock Futures Pare Losses After Retail Sales Number

Stock futures continue to point to a lower open after April's retail sales numbers rise.

Morning Briefing: 10 Things You Should Know

Morning Briefing: 10 Things You Should Know

U.S. stock futures point lower ahead of a retail sales report; Elan and Theravance in a $1 billion royalty agreement; Post Holdings and Take-Two report earnings.

Stocks to Watch: Elan, Theravance, Take-Two

Stocks to Watch: Elan, Theravance, Take-Two

Elan and Theravance enter a $1 billion royalty agreement.

4 Stocks Spiking on Big Volume

4 Stocks Spiking on Big Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Buffett's Long-Term, High-Dividend Plays

Buffett's Long-Term, High-Dividend Plays

Eric Winter details Warren Buffett's favorite dividend-paying stocks.

Theravance Inc. (THRX): Today's Featured Health Care Laggard

Theravance Inc. (THRX): Today's Featured Health Care Laggard

Theravance was a leading decliner within the health care sector, falling $0.63 (-1.9%) to $31.93 on average volume